relapse
Showing 26 - 50 of 74
Hematologic Malignancies, Relapse, GVHD Trial in Ann Arbor (Carfilzomib, Tacrolimus)
Completed
- Hematologic Malignancies
- +2 more
-
Ann Arbor, MichiganUniversity of Michigan Hospital
Dec 3, 2021
Hodgkin Lymphoma, Adult, Relapse, Refractory Hodgkin Lymphoma Trial in Tianjin (PD-1 inhibitor)
Recruiting
- Hodgkin Lymphoma, Adult
- +2 more
- PD-1 inhibitor
-
Tianjin, Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Dec 14, 2021
Lymphoma, Hodgkin's Disease, Relapse Trial in Houston (TGFbeta resistant LMP-specific CTLs)
Active, not recruiting
- Lymphoma
- +3 more
- TGFbeta resistant LMP-specific CTLs
-
Houston, Texas
- +1 more
Dec 8, 2021
Acute Leukemia, Relapse, Hematopoietic Stem Cell Transplantation Trial in Guangzhou (Sorafenib)
Recruiting
- Acute Leukemia
- +2 more
-
Guangzhou, Guangdong, ChinaDepartment of Hematology,Nanfang Hospital, Southern Medical Univ
Oct 30, 2021
Schizophrenia, Mental Disorder, Educational Problems Trial in Bordeaux (Psychoeducation)
Recruiting
- Schizophrenia
- +7 more
- Psychoeducation
-
Bordeaux, FranceCentre Hospitalier Charles PERRENS
Aug 17, 2021
Relapse, Quality of Life, Complication Trial in Caen, Saint-Lô (Ingrown toenails with surgery with chemical cauterisation,
Unknown status
- Relapse
- +3 more
- Ingrown toenails with surgery with chemical cauterisation
- Ingrown toenails with only surgery
-
Caen, Normandie, France
- +1 more
Jun 9, 2021
Alcohol Use Disorder, Stress Reaction, Social Stress Trial in Mannheim (Trier Social Stress Test, Ergometer, Barlab-Exposure)
Recruiting
- Alcohol Use Disorder
- +6 more
- Trier Social Stress Test
- +3 more
-
Mannheim, Baden-Württemberg, GermanyKlinik für Abhängiges Verhalten, Zentralinstitut für Seelische G
Apr 21, 2021
Ketamine IV Classic Protocol : Five Years Follow up
Completed
- Major Depressive Disorder
- +3 more
- Non
-
Tel HaShomer, IsraelThe Chaim Sheba Medical Center
Mar 30, 2021
Wilms Tumor, Relapse, Death Trial in Mansoura (P53, Ki67 and Cyclin A IHC.)
Unknown status
- Wilms Tumor
- +2 more
- P53, Ki67 and Cyclin A IHC.
-
Mansoura, Dakahlia, EgyptMansoura Urology and Nephrology Center. Faculty of Medicine, Man
Feb 16, 2021
After Surgical Treatment for GERD
Completed
- Patient Satisfaction
- +3 more
- 10 years follow up
-
Stockholm, Region Stockholm, SwedenErsta Hospital
Feb 3, 2021
Dual-target CAR-T Cells, B ALL, Relapse Trial in Shenzhen (Dual target CAR-T cell therapy)
Unknown status
- Dual-target CAR-T Cells
- +3 more
- Dual target CAR-T cell therapy
-
Shenzhen, Guangdong, ChinaShenzhen University General hospital
Jan 23, 2021
Heroin Addiction, Relapse Trial in Xi'an (Repetitive transcranial magnetic stimulation)
Unknown status
- Heroin Addiction
- Relapse
- Repetitive transcranial magnetic stimulation
-
Xi'an, Shaanxi, ChinaTangdu Hospital
Jan 20, 2021
Relapse Trial in Aarhus, Oslo (Bonding of either CAD/CAM or conventional multistranded stainless steel fixed retainer)
Active, not recruiting
- Relapse
- Bonding of either CAD/CAM or conventional multistranded stainless steel fixed retainer
-
Aarhus, Denmark
- +1 more
Dec 17, 2020
Lymphoma, Relapse Trial in France (Lenalidomide, Rituximab)
Completed
- Lymphoma
- Relapse
-
Clermont-Ferrand, Auvergne, France
- +11 more
Dec 14, 2020
Different Antiviral Regimens for Hepatitis C Virus Relapse
Unknown status
- Hepatitis C
- +2 more
- directly acting antivirals
-
Alexandria, EgyptAlexandria University.
Dec 4, 2020
Hematological Malignancies, Regulatory T Cell Depletion, Relapse Trial in Creteil (T-reg depleted DLI, Standard DLI)
Recruiting
- Hematological Malignancies
- +2 more
- T-reg depleted DLI
- Standard DLI
-
Creteil, FranceHenri Mondor Hospital
Nov 19, 2020
Interferon-A-2B, Relapse, Prevention Trial in Beijing (Interferon-alpha)
Withdrawn
- Interferon-A-2B
- +3 more
-
Beijing, ChinaPeking University People's Hospital
Sep 21, 2020
Cognitive Impairment, Relapse, Bipolar Disorder Trial in Guangzhou (Repetitive Transcranial Magnetic Stimulation, Sham
Completed
- Cognitive Impairment
- +2 more
- Repetitive Transcranial Magnetic Stimulation
- Sham repetitive transcranial magnetic stimulation
-
Guangzhou, Guangdong, ChinaGuangzhou Brain hospital(Guangzhou Huiai Hospital)
Apr 23, 2020
Donor Lymphocyte Infusion, Allogeneic Hematopoietic Stem Cell Transplantation, Acute Leukemia Trial in Beijing (donor lymphocyte
Unknown status
- Donor Lymphocyte Infusion
- +5 more
- donor lymphocyte infusion
-
Beijing, Beijing, ChinaPeking University Institute of Hematology,Beijing
Mar 9, 2020
Hodgkin Lymphoma in First Complete Remission
Completed
- Hodgkin Lymphoma
- +2 more
- Standard cohort: Clinical lab follow-up
- Imaging cohort: integrated imaging follow-up
- (no location specified)
Mar 4, 2020
Minimal Residual Disease, Donor Lymphocyte Infusion, Hematopoietic Stem Cell Transplantation Trial in Guangzhou (donor
Completed
- Minimal Residual Disease
- +3 more
- donor lymphocyte infusion
-
Guangzhou, Guangdong, ChinaDepartment of Hematology,Nanfang Hospital, Southern Medical Univ
Feb 24, 2020
Multiple Sclerosis, Relapse, Primary Progressive Multiple Sclerosis Trial in Paris (Ocrelizumab)
Recruiting
- Multiple Sclerosis
- +2 more
-
Paris, FranceHôpital Saint-Antoine - Service de Neurologie
Jan 27, 2020